Compare PLSE & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | IRMD |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2015 | 2014 |
| Metric | PLSE | IRMD |
|---|---|---|
| Price | $25.48 | $92.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $22.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 338.8K | 97.5K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $840.00 | $12.38 |
| Revenue Next Year | $287.54 | $11.31 |
| P/E Ratio | ★ N/A | $199.32 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $12.56 | $50.88 |
| 52 Week High | $27.98 | $107.90 |
| Indicator | PLSE | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.22 | 61.17 |
| Support Level | $17.58 | $92.51 |
| Resistance Level | $27.14 | $98.31 |
| Average True Range (ATR) | 1.84 | 2.78 |
| MACD | 0.49 | 1.12 |
| Stochastic Oscillator | 73.39 | 94.94 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.